PALO ALTO, Calif. and LONDON, Oct. 8 -- Anacor Pharmaceuticals and GlaxoSmithKline today announced that they have entered into a worldwide strategic alliance for the discovery, development and ...

Phase I/II trial assessing the safety and efficacy of RECCE ® 327 (R327), a broad-spectrum anti-infective as a topical treatment, met all primary endpoints R327 was well-tolerated in all patients, ...

Clinically Tested Innovation Offers Powerful, Mess-Free Treatment, Symptom Relief and Prevention. BOSTON, Sept. 3, 2025 /PRNewswire/ -- Propedix, an innovator in anti-infective topical dermatology ...

RECCE ® 327 as a gel formulation (R327G) demonstrated a positive clinical response in the treatment of multiple antibiotic-resistant infections under the Therapeutic Goods Administration (TGA) Special ...

Recce’s anti-infective pipeline includes three patented, broad-spectrum, synthetic polymer anti-infectives: RECCE ® 327 (R327) as an intravenous and topical therapy that is being developed for the ...

EMERYVILLE, Calif., March 7 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE Alternext: NBY), a mid-stage biopharmaceutical company developing first-in ...

Registrational Phase 3 trial for diabetic foot infections to be conducted across Indonesia, one of the world's largest diabetes patient populations Awarded expedited regulatory review status in ...

WASHINGTON, D.C. (October 28, 2008) — Scientists at NanoBio Corporation have demonstrated for the first time in humans that a novel topical treatment for cold sores (herpes labialis), NB-001, speeds ...

Antimicrobial resistance (AMR) has long been recognized as a threat to treat infections, and in 2019, the World Health Organization (WHO) declared AMR one of the top 10 global public health threats.

COPENHAGEN Axellia Pharmaceuticals on Tuesday announced its acquisition of the Phoenix Global Supply Group, based in White Plains, N.Y., to supply over-the-counter topical anti-infectives to the U.S.

This Collection invites perspectives on the historical, socio-cultural and bio-medical facets of anti-infectives, including failure and success stories of anti-infective drugs, a discourse of ...

Steven Feldman, MD, PhD, professor of dermatology at Wake Forest School of Medicine, discusses what makes clascoterone (Winlevi) different from past acne treatments. Clascoterone cream 1% is a ...